Medical Devices Startups

My Emergency Doctor operates a telehealth service connecting Australian healthcare institutions with senior emergency physicians, providing remote specialist emergency care regardless of location or time of day.

1 investor

Hellenic Healthcare Group operates a network of private hospitals and primary healthcare services in Greece and Cyprus. The group manages multiple hospital facilities and primary care centers, and has established an educational academy focused on medical training and research.

1 investor

binx health develops FDA-cleared, CLIA-waived point-of-care diagnostic testing for chlamydia and gonorrhea in male and female patients, delivering central-lab-quality results in about thirty minutes so patients can test, get diagnosed, and receive treatment in one visit. The company operates in the diagnostics and sexual health space serving healthcare providers and their patients.

1 investor

MyCancerPath operates a national network of cancer navigators who help patients and families understand diagnoses, biomarker testing, and treatment options while providing doctors with additional clinical support. The service focuses on precision oncology and improving patient outcomes through personalized guidance.

1 investor

CREATE Medicines develops in vivo CAR immunotherapy using proprietary mRNA-LNP technology to program T cells, NK cells, and myeloid cells directly within the body for cancer, autoimmunity, and fibrosis. The company's multi-immune platform enables off-the-shelf therapies with repeat dosing capability.

1 investor

MYHIXEL develops medical devices and technology-based solutions for male sexual health, including products for ejaculatory control, erectile function, and pelvic floor strengthening. The company combines clinical evidence with digital platforms and physical devices designed for home use.

1 investor

Myka Labs develops AI-powered sensor systems and medical devices for minimally invasive surgical repair of congenital birth defects, particularly tracheoesophageal malformations. The company creates sensorized catheters and imaging augmentation technology for pediatric and general surgeons.

1 investor

Myma Medical develops autoICSI, an automation system for the ICSI (intracytoplasmic sperm injection) procedure used in IVF clinics, applying AI for gamete selection and automating gamete pickup and micro-manipulation. The technology aims to reduce embryologists' time-consuming tasks and improve workflow in assisted reproduction.

1 investor

Myolex develops a portable, non-invasive muscle assessment device based on electrical impedance myography (EIM) that measures single-muscle composition and structure to aid diagnosis, prognosis, and treatment monitoring of neuromuscular and musculoskeletal diseases such as ALS. It serves clinicians, researchers, and pharmaceutical companies, with applications in clinical trials and at-home patient monitoring.

1 investor

Myomo develops wearable robotic orthoses to restore arm and hand function for individuals with limited mobility due to stroke, brachial plexus injury, or spinal cord injury. The company serves patients and healthcare providers in the medical device and rehabilitation markets.

1 investor

Cadre Bioscience partners with innovators to develop and bring new therapeutics to clinical application through drug development.

1 investor

Myoptechs develops treatments and interventions for myopia, a progressive eye disease that causes worsening distance vision and can lead to sight-threatening complications. The company targets patients and their eye care providers seeking to reduce both short- and long-term vision complications from myopia.

1 investor

Myrobalan Therapeutics is a pre-clinical biotech company developing small molecule therapies targeting microglia and oligodendrocytes to address neurodegeneration and demyelinating disorders. The company's precision medicines aim to promote remyelination and reduce neuroinflammation in conditions such as multiple sclerosis, Alzheimer's disease, and ALS.

1 investor

MySecondEar is Germany's leading digital hearing aid provider, offering hearing devices, accessories, and professional fitting services both online and at physical locations. The company serves customers seeking accessible, transparent hearing solutions through a combination of digital and in-person support.

1 investor

MyUTI is a platform providing UTI testing and support services for women with frequent and stubborn urinary tract infections. The company addresses gaps in women's health diagnostics and treatment by offering reliable testing solutions and clinical guidance.

1 investor

n6 is a genomics technology company that develops methods and tools for molecular R&D and genomics research. The company serves researchers and genomics labs.

1 investor

NAAMA Studios provides laser tattoo removal and permanent makeup removal services using proprietary LightSense® technology, an FDA-cleared and clinically-backed system designed for safety and efficacy across all skin types.

1 investor

Based on the page listing "Ophthalmic Pharmaceutical Consultant" and "Chief Clinical Officer" roles, Nacuity appears to be a pharmaceutical company focused on ophthalmology (eye care), though the page provides insufficient detail to confirm products, customer base, or market focus.

1 investor

NADMED offers laboratory kits and analytical services for quantifying NAD and glutathione metabolites in research and diagnostic applications. The company provides CE-marked diagnostic kits, research-use-only kits, and custom quantification services for researchers and labs studying redox metabolism.

1 investor

Naegis Pharmaceuticals is a drug discovery and development company creating first-in-class small-molecule treatments for serious ophthalmic and inflammatory diseases. Its work targets inflammatory mechanisms, including leukotriene pathways, to develop new therapies for eye diseases.

1 investor

Nahtlos develops medical electrodes designed for reliable performance in long-term medical applications.

1 investor

Nakamo builds AI companions for medical device manufacturers to monitor technical documentation for consistency, completeness, and traceability within existing systems. The platform helps MedTech teams reduce time spent on documentation cross-checking and compliance work.

1 investor

Nami Surgical is a company developing surgical technology and seeks investors and partners across clinical, commercial, and technological domains. The company is based in Glasgow, United Kingdom.

1 investor

A firm that guides management and strategy for innovations in outpatient spine surgery.

1 investor